Patient Guide: A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 26 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05537740
Status: ACTIVE_NOT_RECRUITING
Condition: Advanced Solid Tumors
Phase: PHASE1

Find a Study Location Near You

This study is available at 26 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Chicago, Illinois
  • Chapel Hill, North Carolina
  • San Antonio, Texas
  • • And 23 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily